UH Seidman discovers newly-approved NSCLC could also treat rare advanced pancreatic cancer

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

University of Michigan Health Rogel Cancer Center received a $50 million gift from Richard and Susan Rogel for pancreatic cancer research and care.

November 08, 2024

Vol.50 No.42

Clinical Roundup

Survey shows dangerous knowledge gaps in pancreatic cancer

While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows that most people continue to believe that pancreatic disease affects only elderly people—and that there is nothing they can do to...

November 08, 2024

Vol.50 No.42

In Brief

SU2C announces grants supporting research in six cancer types

Stand Up To Cancer announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal, and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.

October 18, 2024

Vol.50 No.39

Clinical Roundup

UT Health San Antonio creates pancreatic cancer organoid

A study by scientists at the University of Texas Health Science Center at San Antonio provides one of the first models to study the progression of normal human pancreatic cells toward tumor cells.

October 04, 2024

Vol.50 No.37

Drugs & Targets

FDA approves neoadjuvant/adjuvant Opdivo for resectable NSCLC

FDA approved Opdivo (nivolumab) with platinum-doublet chemotherapy as neoadjuvant treatment, followed by single-agent Opdivo after surgery as adjuvant treatment, for adults with resectable (tumors ≥ 4 cm and/or node positive) non-small cell lung cancer and no known epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.

October 04, 2024

Vol.50 No.37

In Brief

Medical College of Wisconsin receives donation for pancreatic cancer research in honor of Bob Uecker

Debbie Attanasio and Milwaukee Brewers owner Mark Attanasio pledged their support to the Medical College of Wisconsin for pancreatic cancer research with a gift in honor of legendary Hall of Fame Brewers broadcaster Bob Uecker.

September 20, 2024

Vol.50 No.35

UH Seidman discovers newly-approved NSCLC could also treat rare advanced pancreatic cancer

YOU MAY BE INTERESTED IN

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

Survey shows dangerous knowledge gaps in pancreatic cancer

SU2C announces grants supporting research in six cancer types

UT Health San Antonio creates pancreatic cancer organoid

FDA approves neoadjuvant/adjuvant Opdivo for resectable NSCLC

Medical College of Wisconsin receives donation for pancreatic cancer research in honor of Bob Uecker

Renew today!

Subscriber content

Login